1 recruiting, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SGLT2i, Pioglitazone, and Ketone Production in T1D Dapagliflozin 10mg Tab, Pioglitazone 15 MG and 30mg, Placebo - Type1diabetes | Phase 3 | Recruiting | The University of Texas Health Science Center at San Antonio | 24 | 2026-07-01 | 2026-07-20 |
| A Fully Automated Lyumjev and Pramlintide Delivery System for Adults With Type 1 Diabetes Pramlintide, Lyumjev, Automated Insulin Delivery (AID) system - type1diabetes, Diabetes Mellitus, Type 1 | Phase 2 / Phase 3 | Unknown | McGill University Health Centre/Research Institute of the McGill University Health Centre | 30 | 2023-11-30 | 2024-04-18 |
Diabetes Mellitus, Type 1 (1) · Insulin Resistance (1)
Autoimmune Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperinsulinism (1) · Immune System Diseases (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1)
Drug Delivery Systems (1) · Insemination, Artificial, Heterologous (1) · Pioglitazone (1) · dapagliflozin (1) · pramlintide (1)
McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · The University of Texas Health Science Center at San Antonio (1)
Canada (1) · United States (1)
Ahmad Haidar, Ph.D. (1) · Laurent Legault, M.D. (1) · Melissa-Rosina Pasqua, M.D. (1) · Michael Tsoukas, M.D. (1) · Michael Vallis, Ph.D. (1) · Muhammad Abdul-Ghani, MD (1) · Natasha Garfield, M.D. (1) · Ralph DeFronzo, MD (1)
R01DK024092 (1)